Health System Change in the Wake of COVID-19
Description
No abstract
PubMed COVID-19 Clinical Care
581 - 590 of 1647 results found
How Long that a SARS-CoV-2 Variant Delay Impacts Required Period to Achieve Herd Immunity?
Description
No abstract
Hybrid health regimes: Access to primary care physicians and COVID-19 vaccine uptake across municipalities in Romania
Description
This study analyses COVID-19 vaccine uptake at the municipal level in Romania using the global health regimes and vaccine hesitancy perspectives. Our spatial regression (SARAR-het Durbin) shows that the number of primary care physicians is a
Hyperthyroidism incidence in a large population-based study in northeastern Italy
Description
CONCLUSIONS: we documented a decline in the incidence of hyperthyroidism in the Veneto region, paralleling the improvement of the iodine status, thanks to a long and sustained iodine prophylaxis campaign. SARS-CoV-2 pandemic and vaccination campaign
Healthcare professional and manager perceptions on drivers, benefits, and challenges of telemedicine: results from a cross-sectional survey in the Italian NHS
Description
CONCLUSIONS: Respondents believe that telemedicine can be useful to complement and augment traditional care. However, many challenges still need to be overcome to fully consider telemedicine a standard of care. Strategies that could help address
High-Flow Nasal Cannula oxygen therapy in COVID-19: retrospective analysis of clinical outcomes - single center experience
Description
CONCLUSION: High-Flow Nasal Cannula oxygen therapy is a safe type of respiratory support in patients with COVID-19 pneumonia and acute hypoxemic respiratory failure with significantly less possibility for emergence of intrahospital infections. In 52%
HLA haplotypes and differential regional mortality caused by COVID-19 in Brazil: an ecological study based on a large bone marrow donor bank dataset
Description
The coronavirus disease 2019 (COVID-19) mortality rates varied among the states of Brazil during the course of the pandemics. The human leukocyte antigen (HLA) is a critical component of the antigen presentation pathway. Individuals with different